Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank I Lin

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Molecular Imaging and Biology|April 23, 2021
Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [<sup>18</sup>F]DCFPyL PET ImagingJyoti Roy, Margaret E White, Falguni Basuli, et al.
Cell Metabolism|August 11, 2016
Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in HumansKong Y Chen, Aaron M Cypess, Maren R Laughlin, et al.
Frontiers in Endocrinology|October 27, 2023
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [<sup>177</sup>Lu]Lu-DOTA-TATE therapySriram Gubbi, Mohammad Al-Jundi, Sungyoung Auh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2016
Utility of <sup>18</sup>F-fluoroestradiol (<sup>18</sup>F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapyFrank I Lin, E M Gonzalez, S Kummar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2017
Superiority of <sup>68</sup>Ga-DOTATATE over <sup>18</sup>F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric populationAbhishek Jha, Alexander Ling, Corina Millo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2022
<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine TumorsA Paden King, Nicholas T Gutsche, Natarajan Raju, et al.
Cancers|August 26, 2022
Performances of Functional and Anatomic Imaging Modalities in <i>Succinate Dehydrogenase A-</i>Related Metastatic Pheochromocytoma and ParagangliomaMayank Patel, Abhishek Jha, Alexander Ling, et al.
Abdominal Radiology (New York)|February 3, 2016
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot studyBaris Turkbey, Maria L Lindenberg, Stephen Adler, et al.
The Prostate|September 1, 2020
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meetingAndrea K Miyahira, Kenneth J Pienta, John W Babich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2025
Erratum: Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and BiomarkersFrank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Molecular Imaging and Biology|April 23, 2021
Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [<sup>18</sup>F]DCFPyL PET ImagingJyoti Roy, Margaret E White, Falguni Basuli, et al.
Cell Metabolism|August 11, 2016
Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in HumansKong Y Chen, Aaron M Cypess, Maren R Laughlin, et al.
Frontiers in Endocrinology|October 27, 2023
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [<sup>177</sup>Lu]Lu-DOTA-TATE therapySriram Gubbi, Mohammad Al-Jundi, Sungyoung Auh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 23, 2016
Utility of <sup>18</sup>F-fluoroestradiol (<sup>18</sup>F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapyFrank I Lin, E M Gonzalez, S Kummar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2017
Superiority of <sup>68</sup>Ga-DOTATATE over <sup>18</sup>F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric populationAbhishek Jha, Alexander Ling, Corina Millo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2022
<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine TumorsA Paden King, Nicholas T Gutsche, Natarajan Raju, et al.
Cancers|August 26, 2022
Performances of Functional and Anatomic Imaging Modalities in <i>Succinate Dehydrogenase A-</i>Related Metastatic Pheochromocytoma and ParagangliomaMayank Patel, Abhishek Jha, Alexander Ling, et al.
Abdominal Radiology (New York)|February 3, 2016
PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot studyBaris Turkbey, Maria L Lindenberg, Stephen Adler, et al.
The Prostate|September 1, 2020
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meetingAndrea K Miyahira, Kenneth J Pienta, John W Babich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2025
Erratum: Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and BiomarkersFrank I Lin, Jaydira Del Rivero, Jorge A Carrasquillo, et al.
Pageof 5